References
Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R (2017) Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg 124:44–51. https://doi.org/10.1213/ANE.0000000000001683
Perez Jimenez TE, Kukanich B, Joo H et al (2019) Oral coadministration of fluconazole with tramadol markedly increases plasma and urine concentrations of tramadol and the O – desmethyltramadol metabolite in healthy dogs. Drug Metab Dispos 47:15–25. https://doi.org/10.1124/dmd.118.083444
Stahl SM (2016) Parkinson’s disease psychosis as a serotonin – dopamine imbalance syndrome. CNS Spectr 21:355–359. https://doi.org/10.1017/S1092852916000602
Smith HS, Laufer A (2014) Opioid induced nausea and vomiting. Eur J Pharmacol 722:67–78. https://doi.org/10.1016/j.ejphar.2013.09.074
Rickli A, Liakoni E, Hoener MC, Liechti ME (2018) Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol 175:532–543. https://doi.org/10.1111/bph.14105
Kovács G, Péter L (2010) Complex hallucination (visual – auditory) during coadministration of tramadol and clarithromycin. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja= official journal of the Hungarian association of. Psychopharmacology 12:309–312
Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V, Antoniazzi S, Pozzi M, Clementi E, Radice S (2013) Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol 69:1615–1616
Kirchheiner J, Keulen J-TH, Bauer S et al (2008) Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol 28:78–83
Lai J, Ma S, Porreca F, Raffa RB (1996) Tramadol. M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9. 10 neuroblastoma cells. Eur J Pharmacol 316:369–372
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Delafoy, C., Dolladille, C., Besnier, P. et al. Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism. Eur J Clin Pharmacol 76, 1049–1051 (2020). https://doi.org/10.1007/s00228-020-02881-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-020-02881-5